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Introduction {#sec1}
============

Multiple chromatin alterations are found in cancer, such as mutations and changes in the expression of histones, chromatin remodeling factors, histone chaperones, and enzymes that post-translationally modify histones (reviewed in [@bib15], [@bib16], [@bib33]). The benefits that these alterations provide to tumor cells are unclear. The prevailing hypothesis is that these alterations lead to changes in the expression of genes that promote cell growth or inhibit differentiation and cell death. However, this hypothesis is not completely satisfying because it does not explain how chromatin alterations (e.g., mutations in core histones) with extensive genome-wide effects can lead to changes in the transcription of specific genes that are beneficial for cancer cells.

One example of such an alteration is the frequent overexpression of histone chaperone FACT (Facilitates Chromatin Transcription) in multiple human tumors ([@bib4], [@bib9], [@bib17], [@bib20]). FACT consists of two subunits in higher eukaryotes: Structure Specific Recognition Protein 1 (SSRP1) and Suppressor of Ty 16 (SPT16). Both subunits are highly conserved in all eukaryotes and perform similar functions. They interact with all components of the nucleosome (i.e., histone oligomers and DNA) and are involved in replication, transcription, and DNA repair (reviewed in [@bib22]). FACT is not only overexpressed in different types of tumors but also associated with poor prognosis ([@bib4], [@bib20], [@bib1], [@bib7]). Moreover, genetic or chemical inhibition of FACT has strong anti-cancer effects in multiple cancer models ([@bib4], [@bib20], [@bib7], [@bib21]). At the same time, mammalian FACT is not expressed or is expressed at much lower levels in non-tumor cells *in vitro* and in differentiated cells *in vivo* ([@bib19]). Inhibition of FACT in FACT-positive normal cells has little effect on cell growth or viability ([@bib20], [@bib36], [@bib28]). These findings suggest that FACT may be a promising target for anti-cancer treatment. However, how FACT supports the viability of tumor cells is unclear.

In cell-free experiments, FACT was essential for transcription elongation through nucleosomal DNA ([@bib39], [@bib40]). Based on these data, when we first noticed that FACT was enriched at coding regions of so-called pro-cancerous genes (i.e., genes involved in cell proliferation, response to stress, and maintenance of pluripotency) ([@bib20]), we assumed that FACT was involved in the transcription elongation of these genes, many of which are essential for tumor growth. However, there were many unclear issues with this interpretation. Several groups recently reported that mammalian FACT could not bind the folded nucleosome ([@bib5], [@bib13], [@bib44], [@bib49], [@bib50]), which makes it difficult to explain how FACT can remove the nucleosomal barrier for transcription and replication. It is also unclear how FACT selects genomic regions because it does not have sequence-specific DNA binding or histone modification "reader" domains. If the elongating RNA polymerases recruited FACT, then why would its inhibition be much more toxic for tumor than normal cells? Furthermore, depletion of FACT from tumor cells, which were the most sensitive to FACT knockdown, did not result in the inhibition of the expression of "pro-cancerous" genes ([@bib17]). Similarly, it was recently shown that there was no inhibition of the transcription of FACT-enriched genes in mouse embryonic stem cells or human fibroblasts ([@bib36], [@bib28]).

The aim of this study was to compare the effect of FACT loss in syngeneic mammalian cells at different stages of tumorigenic transformation to understand whether FACT has special function in transformed and tumor cells.

Results {#sec2}
=======

Development of Conditional *Ssrp1* Knockout Cell Model with Different Basal Levels of FACT {#sec2.1}
------------------------------------------------------------------------------------------

Previously, we observed that tumor cells express higher levels of the FACT subunits and their viability is more dependent on FACT expression than primary or immortalized non-tumor cells ([@bib19], [@bib20], [@bib22]). To understand the mechanism of this difference in FACT dependency, we generated isogenic cells from mouse skin fibroblasts (MSFs) isolated from *Ssrp1*^*fl/fl*^*;CreER*^*T2+/+*^ mice, in which the *Ssrp1* gene can be deleted by tamoxifen treatment ([@bib45]). As a negative control, we used cells from *Ssrp1*^*fl/+*^*;CreER*^*T2+/+*^ mice because deletion of one allele of *Ssrp1* did not affect the mouse phenotype ([@bib3]). We previously demonstrated that depletion of SSRP1 leads to an efficient and rapid loss of both SSRP1 and SPT16 proteins ([@bib44]). Thus, the whole FACT complex can be eliminated from these cells by the administration of the active metabolite of tamoxifen, 4-hydroxytamoxifen (4-OHT).

Primary MSFs are highly sensitive to contact inhibition, survive in culture for four to five passages, and then undergo replicative senescence. The MSFs were transduced with the genetic suppressor element (GSE) 56, an inhibitor of tumor suppressor p53 ([@bib41]). MSF-GSE56 cells became immortal but were still sensitive to contact inhibition ([Figure 1](#fig1){ref-type="fig"}A), did not grow in semisolid medium, and did not form tumors in mice. MSF-GSE56 cells were subsequently transduced with the mutant H-Ras^V12^ oncogene. These cells (MSF-GSE56-HRas) lost contact inhibition and formed foci in dense culture ([Figure 1](#fig1){ref-type="fig"}A). They also grew in semisolid medium and quickly developed aggressive tumors in mice ([Figure 1](#fig1){ref-type="fig"}B), i.e., acquired a fully transformed phenotype. The primary MSFs had low but detectable levels of SSRP1 and SPT16, which were elevated in immortalized MSF-GSE56 cells and further increased in the transformed MSF-GSE56-HRas cells ([Figure 1](#fig1){ref-type="fig"}A). In all experiments, we used primary cell cultures isolated from two to four individual mice as biological replicates, which were independently immortalized and then transformed as described earlier. The main figures include the mean data for all tested cell variants or representative images. Data for additional cell variants are available in the supplementary materials. Cultures of immortalized and transformed cells generated from the same primary cells are labeled with the same number.Figure 1Development of Conditional *Ssrp1* Knockout Cell Model with Different Basal Levels of FACT(A) Primary (Pr) mouse skin fibroblasts (MSFs) were isolated from tail tips of *Ssrp1*^*fl/fl*^*;CreERT*^*2+/+*^ mice and transduced with GSE56 to become immortalized (Im) or GSE56 and HRas^V12^ oncogene to become transformed (Tr). (Top) Methylene blue staining of plates with corresponding cells at confluency. (Bottom) Western blotting of the lysates of the corresponding cells probed with the indicated antibodies.(B) Growth of Tr cells in severe combined immunodeficiency mice. Representative photographs of mice and tumors on day 32 after inoculation of transformed cells.

Loss of FACT Compromises Replication and Causes Death of Transformed but Not Primary Normal Cells {#sec2.2}
-------------------------------------------------------------------------------------------------

4-OHT administration resulted in the disappearance of *Ssrp1* mRNA and SSRP1 and SPT16 proteins between days 3 and 5 after the start of treatment ([Figures 2](#fig2){ref-type="fig"}A, [S1](#mmc1){ref-type="supplementary-material"}A, and S1B). 4-OHT treatment did not affect the growth of primary cells but led to significant reduction in the number of the transformed and, to a lesser extent, the immortalized cells compared with untreated control ([Figures 2](#fig2){ref-type="fig"}B and [S1](#mmc1){ref-type="supplementary-material"}C). Importantly, tumors that formed from the transformed cells in severe combined immunodeficiency mice quickly disappeared after the administration of tamoxifen to mice ([Figures 2](#fig2){ref-type="fig"}C and [S2](#mmc1){ref-type="supplementary-material"}).Figure 2Different Consequences of FACT Depletion in Primary (Pr), Immortalized (Im), and Transformed (Tr) Cells(A) Excision of *Ssrp1*^*fl/fl*^ results in disappearance of SSRP1 and SPT16 proteins after 4 days of treatment with 4-OHT. Western blotting of extracts of Im cells at indicated time points after start of treatment with 4-OHT probed with the indicated antibodies.(B) Viability of Pr, Im, and Tr cells with and without FACT. All cells were plated at equal numbers after the end of treatment with 4-OHT (5 days). 2 days later the relative number of cells was assessed using resazurin/resorufin cell viability assay. Bars are means of four cell lines, isolated from individual mice of each genotype ± SD (see [Figure S1](#mmc1){ref-type="supplementary-material"}C for data of individual cell lines).(C) Growth of Tr cells in severe combined immunodeficiency mice treated with tamoxifen or vehicle. Average tumor volume ± SD. (See also [Figure S2](#mmc1){ref-type="supplementary-material"}).(D) Quantitation of the cell cycle distribution data obtained from cells replated at the end of 4-OHT treatment and grown for 24 h. Bars are means of two cell lines isolated from individual mice ± SD (see [Figure S3](#mmc1){ref-type="supplementary-material"} for each cell line).(E) EdU incorporation into different cells treated or not with 4-OHT. Bars are means of two cell lines ± SD (see [Figure S1](#mmc1){ref-type="supplementary-material"}D for each cell line).(F) Normalized average number of anaphase bridges per number of mitosis. Bars are mean of two cell lines ± SD. Control cells of each variant = 1.(G) Activities of caspases 3 and 7 in the cells with and without 4-OHT treatment assessed at the moment (0 h) and at different time points after caspase substrate addition. Bars are means of two replicates of two cell cultures of each genotype ± SD (see [Figure S4](#mmc1){ref-type="supplementary-material"} for each cell line). ∗p \< 0.05.

To figure out whether FACT-depleted immortalized and transformed cells stop growing or die we first analyzed cell cycle using flow cytometry. The cell cycle distribution of the primary cells remained unchanged following 4-OHT treatment, whereas transformed and, to a lesser extent, immortalized, cells were accumulated in the S and G2/M phases ([Figures 2](#fig2){ref-type="fig"}D and [S3](#mmc1){ref-type="supplementary-material"}). At the same time the proportion of cells with ongoing DNA replication, as judged by incorporation of 5-ethynyl-2′-deoxyuridine (EdU), was reduced in transformed and immortalized cells after FACT depletion ([Figures 2](#fig2){ref-type="fig"}E and [S1](#mmc1){ref-type="supplementary-material"}D). The combination of accumulation of cells in S-phase with reduced proportion of cells capable of DNA synthesis suggests that FACT loss leads to the block of DNA replication in transformed and immortalized cells. The increased proportion of cells in the G2/M phase suggests activation of G2 checkpoint or difficulty in passing through mitosis, what may occur when mitosis starts in cells with unfinished replication or unresolved homologous recombination. There are data showing the functional role of FACT in DNA replication and homologous recombination (reviewed in [@bib22]). The marker of these events is anaphase bridges ([@bib18]). There was significantly elevated number of anaphase bridges after FACT depletion in the transformed, but not in primary, cells ([Figure 2](#fig2){ref-type="fig"}F). There was also increase in the number of anaphase bridges upon FACT depletion in immortalized cells, but the difference did not reach statistical significance. Thus, we concluded that whereas FACT loss has minimal effects in primary cells, in transformed, and to a lesser degree in immortalized, cells, it causes problem with DNA replication, leading to the occurrence of mitosis in cells with not fully replicated DNA. Eventually, cells with significant problems with replication should die and in line with this notion, we also detected activated caspase 3/7 after 4-OHT administration in transformed, and in one of three replicates of immortalized, cells, but not in primary cells ([Figures 2](#fig2){ref-type="fig"}G and [S4](#mmc1){ref-type="supplementary-material"}). 4-OHT did not cause any of these effects in cells obtained from mice heterozygous for *Ssrp1*^*fl*^ allele ([Figures 2](#fig2){ref-type="fig"}, [S1](#mmc1){ref-type="supplementary-material"}, and [S3](#mmc1){ref-type="supplementary-material"}).

Together, these data suggest that FACT loss compromises growth of immortalized and viability of transformed cells. Importantly, the difference in the FACT dependence of cells cannot be explained by the difference in cell proliferation because in basal conditions, immortalized and transformed cells had similar cell cycle profiles and the same number of EdU-positive cells in the populations ([Figures S1](#mmc1){ref-type="supplementary-material"}D and [S3](#mmc1){ref-type="supplementary-material"}).

Effects of FACT Inactivation on Transcription {#sec2.3}
---------------------------------------------

The problem observed with replication in transformed and immortalized cells following FACT removal may be due to the direct involvement of FACT in replication or because of the loss of FACT-dependent transcription of genes, whose products support replication. We previously observed the binding of FACT to chromatin of genes involved in replication and cell cycle in human tumor cells ([@bib17], [@bib20]).

To discriminate between these scenarios, we assessed the effect of FACT inactivation on global transcription, using the 5-ethynyluridine (EU) incorporation assay, and on transcription of individual genes using next-generation sequencing (NGS) of RNA isolated from cells (RNA sequencing \[RNA-seq\]). Surprisingly, the EU incorporation was increased following *Ssrp1* knockout (KO) in immortalized and transformed cells, but not changed in primary cells ([Figures 3](#fig3){ref-type="fig"}A and [S5](#mmc1){ref-type="supplementary-material"}).Figure 3Effects of FACT Inactivation on Transcription in Primary (Pr), Immortalized (Im) and Transformed (Tr) Mouse Cells(A) EU incorporation into Pr, Im, and Tr cells of two genotypes treated or untreated with 4-OHT for 5 days. As control cells without EU and cells treated with transcription inhibitor actinomycin D (Act D) were used. Data for one cell line of each genotype are shown. Other cell lines are shown in [Figure S5](#mmc1){ref-type="supplementary-material"}.(B--H) Analyses of two biological replicates of paired-end RNA-seq samples of Pr, Im, and Tr homozygous wild-type or floxed *Ssrp1* cells treated or untreated with 4-OHT. Correlation between replicates is shown in [Figure S6](#mmc1){ref-type="supplementary-material"}. (B) Principle-component analysis. Darker colors, 4-OHT; lighter colors, control samples. (C) Number of up- and downregulated genes. Fold change (FC) \> ±1.5, adjusted p value \<0.05. Table shows number of genes in each category. (D) Commonly or differentially up- and downregulated genes in Pr, Im, and Tr cells with floxed *Ssrp1* upon 4-OHT treatment. Venn diagrams for wild-type *Ssrp1* cells are shown in [Figure S7](#mmc1){ref-type="supplementary-material"}A. (E) Fold change (FC) of expression of genes commonly downregulated in Pr, Im, and Tr cells with floxed *Ssrp1* upon 4-OHT treatment. (F) Summary of GSEA. Normalized enrichment scores (NES) are shown for all significantly enriched gene lists in Pr, Im, or Tr cells of either of genotypes. Individual NES plots are shown in [Figure S7](#mmc1){ref-type="supplementary-material"}B. (G) Heat plot demonstrating FC of expression of replication-dependent histones and several housekeeping genes in different conditions between 4-OHT-treated and untreated cells. (H) Violin plots of FC of expression of all replication-dependent histones and selected housekeeping genes, shown in (G) between 4-OHT-treated and untreated cells.

For RNA-seq, we used cells from *Ssrp1*^*fl/fl*^*;CreER*^*T2+/+*^ and *Ssrp1*^*+/+*^*; CreER*^*T2+/+*^ mice to filter out the effect of 4-OHT administration and Cre activation, independent of *Ssrp1* KO. Two biological replicates were used for each condition, and their correlation was \>98% (\>99% in 11 of 12 cases, [Figure S6](#mmc1){ref-type="supplementary-material"}). Principal-component analysis (PCA) confirmed the similarity of all replicates ([Figure 3](#fig3){ref-type="fig"}B). In addition, PCA showed that all primary samples were clustered together independently of their *Ssrp1* alleles. 4-OHT had little effect on the primary cells of either genotype ([Figure 3](#fig3){ref-type="fig"}B). The immortalized and transformed samples diverged from the primary MSFs in two directions: samples from cells with wild-type *Ssrp*1 were found along principal component 1 (PC1) (38.5% variance), and samples from cells with floxed *Ssrp1* alleles were found along PC2 (30.5% variance). The 4-OHT-treated samples from immortalized and transformed cells with floxed *Ssrp1* were clearly separated from the untreated samples, but the impact of 4-OHT administration on the distribution of these samples was very modest and shifted the immortalized and transformed cells with floxed *Ssrp1* alleles closer to the position of the primary cells along PC1 ([Figure 3](#fig3){ref-type="fig"}B). Thus, PCA showed that transcription of genes was changed much stronger due to immortalization and transformation, than due to *Ssrp1* KO. The changes were of a rather random nature as there was a high variance between independently generated immortalized and transformed cells. Because the differences were observed even before *Ssrp1* deletion, it cannot be attributed to FACT inactivation. In line with the phenotypic studies, FACT inactivation had a more prominent effect on gene expression in transformed and immortalized cells than in primary cells.

4-OHT administration altered gene expression in cells of both genotypes with floxed and wild-type *Ssrp1,* and there was significant overlap in downregulated genes in primary cells between the two genotypes ([Figure S7](#mmc1){ref-type="supplementary-material"}), suggesting that the effect of 4-OHT is comparable in these cells with *Ssrp1* deletion. In all cell variants with floxed *Ssrp1* there were more upregulated than downregulated genes upon 4-OHT administration. In contrast, in cells with wild-type *Ssrp1* there were similar numbers of up- and downregulated genes ([Figures 3](#fig3){ref-type="fig"}C and [S7](#mmc1){ref-type="supplementary-material"}A). There were 115 genes commonly upregulated across all three cell types following Ssrp1 KO but only 7 that were downregulated ([Figure 3](#fig3){ref-type="fig"}D). The most significantly and specifically (i.e., only in *Ssrp1*-floxed but not wild-type cells) downregulated gene was *Ssrp1* itself ([Figure 3](#fig3){ref-type="fig"}E). The commonly up- or downregulated genes did not belong to any known gene sets based on gene set enrichment analysis (GSEA).

Surprisingly, when we performed GSEA on genes up- or downregulated after 4-OHT administration in each type of both genotypes, we obtained very similar lists of genes in all cases ([Figures 3](#fig3){ref-type="fig"}F and [S7](#mmc1){ref-type="supplementary-material"}B), suggesting that 4-OHT administration and Cre activation, but not *Ssrp1* KO, might be the major driver of the gene expression changes. No functional gene categories responded to *Ssrp1* KO exclusively in the cells in which we observed strong phenotypic changes (i.e., immortalized and transformed cells with floxed *Ssrp1*). There was significant enrichment of genes involved in cell cycle-related processes (e.g., DNA replication, telomeres, and chromosome maintenance) among genes downregulated by 4-OHT. However, their expression was reduced in both *Ssrp1* floxed and wild-type cells, although this effect was stronger in cells with *Ssrp1* floxed than wild-type alleles. For example, expression of the replication-dependent histone genes, which are highly expressed during the S-phase of the cell cycle, was reduced to a greater extent in *Ssrp1* floxed cells than in *Ssrp1* wild-type cells ([Figures 3](#fig3){ref-type="fig"}G and 3H), which is consistent with the observed phenotypic changes. However, the strongest reduction was observed in primary cells in which we saw no difference in growth or cell cycle distribution upon 4-OHT treatment.

Identification of transcriptional changes in the similar gene lists upon FACT loss in different cells combined with the low number of commonly changed genes suggests that changes in gene expression may be secondary to FACT loss, i.e., in response to dysregulation of certain processes (e.g., replication) rather than direct FACT involvement in the transcription of individual genes. To assess the direct role of FACT in the regulation of expression of individual genes, we calculated correlation between the level of FACT enrichment at a gene, transcription of this gene in basal conditions, and changes in expression of this gene upon *Ssrp1* KO. For this we performed chromatin immunoprecipitation with an SSRP1 antibody followed by NGS (chromatin immunoprecipitation sequencing \[ChIP-seq\]) in immortalized and transformed cells. The level of FACT in the primary cells was too low to accurately run this assay. We observed SSRP1 enrichment at coding regions of genes in proportion to the level of transcription of these genes ([Figure 4](#fig4){ref-type="fig"}A). In immortalized cells, this dependence was stronger than in transformed cells. There was higher level of SSRP1 everywhere, including non-transcribed regions and genes expressed at low levels in transformed cells ([Figures 4](#fig4){ref-type="fig"}A and 4B). This pattern was reproduced with independently generated immortalized and transformed cell cultures from a different mouse and using a different platform for RNA-seq ([Figure S8](#mmc1){ref-type="supplementary-material"}, see details in [Transparent Methods](#mmc1){ref-type="supplementary-material"}). In line with this, significant positive correlation between SSRP1 and RNA read coverage under basal conditions was much stronger in immortalized than transformed cells (Pearson correlation coefficients 0.44 versus 0.12, [Figures 4](#fig4){ref-type="fig"}C and [S9](#mmc1){ref-type="supplementary-material"}A). However, the distribution of nucleosomes in basal conditions measured using histone H3 ChIP-seq was not significantly different between the two cell types ([Figure S8](#mmc1){ref-type="supplementary-material"}).Figure 4Relationship between FACT Genomic Distribution and Transcription in Mouse Cells (*Ssrp1*^*fl/fl*^*; CreER*^*T2+/+*^ \#2)Data for other cell lines are shown on [Figures S8](#mmc1){ref-type="supplementary-material"} and [S9](#mmc1){ref-type="supplementary-material"}.(A) Average enrichment of SSRP1 (ChIP-seq) at genes depending on the levels of their transcription defined by RNA-seq read density in basal conditions.(B) Whisker plot of normalized FACT enrichment at different categories of genomic regions.(C) Dot plot demonstrating relationship between SSRP1 enrichment and transcription.(D) Dot plot demonstrating relationship between SSRP1 enrichment and fold change in gene expression upon *Ssrp1* KO. R, Pearson correlation coefficient.

Next, we looked whether genes that are occupied by FACT would have stronger changes in their transcription upon FACT removal than genes that were not occupied by FACT in basal conditions. For this we assessed correlation between FACT enrichment (SSRP1 ChIP-seq reads) and FACT dependence (fold change of transcription between cells treated with 4-OHT and control cells). In all cases, we saw negative correlation between FACT enrichment and FACT dependence ([Figures 4](#fig4){ref-type="fig"}D, [S9](#mmc1){ref-type="supplementary-material"}B, and S9C). These correlations were highly significant and stronger for immortalized cells than for transformed cells, i.e., loss of FACT led to a stronger increase in gene expression in immortalized cells than in transformed cells, suggesting that the presence of FACT might interfere with gene transcription, and this effect is weakened in transformed cells.

Cell-free experiments showed that the absence of FACT caused RNA polymerase II to pause at several positions within the nucleosome and, therefore, produce early terminated short transcripts ([@bib26]). In addition, several studies in yeast demonstrated that inhibition of FACT was associated with the loss of nucleosomes at the coding regions of genes ([@bib13], [@bib14], [@bib34], [@bib35]), which might lead to cryptic intra-genic initiation. In both cases, non-functional transcripts (i.e., early terminated or incorrectly initiated) might mask the presence of proper full-length transcripts when analyzed using NGS (short reads) or total EU incorporation. However, both types of short transcripts could skew the distribution of reads along the coding region: early termination could generate bias toward an overrepresentation of reads corresponding to the 5′ versus 3′ exons; cryptic initiation could result in an overrepresentation of reads from the 3′ exons. Therefore, we compared the number of reads representing individual exons between samples in the presence or absence of FACT and observed increase in 5′ UTR exons in immortalized and transformed cells lacking FACT ([Figures 5](#fig5){ref-type="fig"}A and 5B). Furthermore, we observed a significant increase in the proportion of reads corresponding to introns in transformed and, to a lesser degree, immortalized cells ([Figures 5](#fig5){ref-type="fig"}A, 5C, [S10](#mmc1){ref-type="supplementary-material"}A, and S10B). This so-called intron retention was previously observed in tumor cells ([@bib48], [@bib10]) and was thought to be the result of mutations in splicing factors ([@bib52]). However, it can also be explained by cryptic initiation from introns due to the loss of nucleosomes. Because we detected "intron retention" in all independently transformed cell cultures concomitant with other signs of chromatin destabilization, we propose that the second explanation is more probable.Figure 5Alterations of Distribution of Transcripts Corresponding to Different Genomic Features upon FACT Loss and Tumorigenic Transformation(A) Distribution of paired-end RNA-seq reads corresponding to different gene regions within individual samples: TES_down_10kb, read located within 10 kb downstream of the transcription end site; TSS_up_10kb, 10 kb upstream of the transcription start site; introns, within the intron of any gene; 3′UTR_Exons, within the last exon of a gene; 5′UTR_Exon, within the first exon of a gene; CDS_Exons, within all other exons of a gene.(B and C) Mean proportion of reads corresponding to the first exon (B) or introns (C) within each category of samples ± SD.(D) Distribution of paired-end RNA-seq reads corresponding to annotated genomic features (Assigned) or not (NoFeatures) as well as reads with questionable annotations (Ambiguity, Chimera, Overlapping_Length) within individual samples.(E) Mean proportion of reads corresponding to regions with no features within each category of samples ± SD. The same color code is used for (B, C, and E). Similar data for single-end RNA-seq are shown on [Figure S10](#mmc1){ref-type="supplementary-material"}.

Another important difference between cells of different types noticed in the process of analysis of the RNA-seq data was significant changes in the proportion of reads mapped to annotated genomic regions versus regions with no features (i.e., lacking any known transcripts or regulatory elements) between primary, immortalized, and transformed cells independently of genotype and 4-OHT treatment ([Figures 5](#fig5){ref-type="fig"}D and 5E). There were significantly more reads with no features in immortalized and transformed cells compared with the primary cells. The appearance of these reads may suggest either contamination of RNA with genomic DNA or that the samples contained elevated levels of products of so-called pervasive transcription from non-coding genomic regions due to the loss of chromatin packaging at these regions ([@bib30]). Because the RNA was isolated simultaneously using the same method for all types of cells, the first explanation (i.e., genomic DNA contamination) seems less probable. However, to exclude this possibility, we analyzed the samples from independently isolated immortalized, and transformed cells from mice with floxed *Ssrp1* using a different method of RNA isolation (Trizol reagent versus purification column) and sequencing platform (single versus paired-end reads). The data generated were consistent with the first set of data ([Figures S10](#mmc1){ref-type="supplementary-material"}C and S10D).

Effect of FACT Inactivation on Transcription in Human Cells {#sec2.4}
-----------------------------------------------------------

To confirm these findings in human cells, we examined the relationship between FACT and gene expression in fibrosarcoma cell line HT1080 for which we already had SSRP1 ChIP-seq data from two independent experiments of two to three replications and data from several gene expression studies using different methods for FACT knockdown (KD) (e.g., SSRP1 short hairpin RNA \[shRNA\], small interfering RNAs \[siRNAs\] to SSRP1 and SPT16). We also had nascent RNA-seq data from the same cells ([@bib37]), which served as a more accurate measure of gene expression, not influenced by the degree of RNA stability. As we previously observed, there was a significant positive correlation between FACT enrichment and the transcription of genes under basal conditions in these cells ([Figure 6](#fig6){ref-type="fig"}A). Interestingly, this dependence was not only quantitative but also qualitative because the profiles of FACT enrichment between 5′ UTR, coding, and 3′ UTR regions were different for genes expressed at different levels ([Figure 6](#fig6){ref-type="fig"}B).Figure 6FACT Genomic Distribution and Transcription in Human Cells(A) Dot plot demonstrating relationship between SSRP1 enrichment (ChIP-seq) and transcription in basal conditions (nascent RNA-seq). R, Pearson correlation coefficient.(B) Metagene profile of SSRP1 (ChIP-seq) distribution at genes depending on the levels of their transcription defined by nascent RNA-seq read density in basal conditions.(C) Dot plot demonstrating relationship between SSRP1 enrichment and fold change in gene expression (RNA-seq) upon SSRP1 knockdown with shRNA.(D) Integrated genomic view of normalized read density of SSRP1 (ChIP-seq, 3 replicates), RNA (RNA-seq, 2 replicates), and input DNA (2 replicates) in cells transduced with control shRNA (−) or shRNA to SSRP1 (+) at three genomic regions surrounding CYR61, PMAIP, and TEX19.(E) Changes in gene expression between shSSRP1 and shControl cells depending on the level of expression in basal conditions using loess normalized counts. Red dots, fold change \>±1.5, adjusted p value \< 0.05.(F) Inverse relationship between two correlation coefficients, R1, SSRP1 enrichment and gene transcription in basal conditions, and R2, SSRP1 enrichment and FC in gene expression upon FACT depletion, for all tested cells. See also [Figure S11](#mmc1){ref-type="supplementary-material"}.

Similar to mouse cells, we saw only a negative correlation between FACT enrichment and FACT dependence independent of how expression was measured, i.e., microarray hybridization or RNA sequencing; what approach was used to suppress gene expression (shRNAs or siRNAs to SSRP1, SUPT16H \[gene coding SPT16\], or both); or whether the correlation analysis was performed using SSRP1 enrichment only at the promoter or coding regions or both ([Figures 6](#fig6){ref-type="fig"}C and [S11](#mmc1){ref-type="supplementary-material"}). For the RNA-seq, we used spike-in controls that allowed us to detect absolute changes in transcription. Consistent with the mouse data, FACT downregulation led to an increase in the transcription of multiple genes. There were more genes enriched for FACT among the upregulated genes than the downregulated genes ([Figures 6](#fig6){ref-type="fig"}D and 6E). For the limited number of cases tested, we observed an inverse relationship between the positive correlation coefficient for FACT enrichment at genes versus the transcription in basal conditions and the negative correlation coefficient for FACT enrichment versus the change in expression of genes upon FACT depletion ([Figure 6](#fig6){ref-type="fig"}F). These data suggest that the influence of FACT on the transcription of genes is dependent on the type of cell. In general, the stronger was the FACT association with the transcribed genes, the higher was the activation of transcription upon FACT inactivation in cells.

FACT Inactivation Leads to Destabilization of Chromatin in Transformed Cells {#sec2.5}
----------------------------------------------------------------------------

Absence of positive effect of FACT on transcription together with the ability of FACT to bind partially unfolded nucleosome and data from lower eukaryotes showing that FACT loss is accompanied by the loss of histones from transcribed regions allows proposing that FACT may help to preserve chromatin at transcribed regions. If this is true in higher eukaryotes, then the loss of FACT should lead to the destabilization of chromatin and suggests a mechanism by which FACT may have negative effect on transcription. If FACT prevents nucleosome loss during transcription, then in the absence of FACT, disassembly of nucleosomes caused by the first RNA polymerase passage should make passage of the next RNA polymerases easier. To test this hypothesis we compared the sensitivity of chromatin to micrococcal nuclease (MNase), which preferentially cleaves protein-free DNA, i.e. leave nucleosomal DNA intact. After 4-OHT treatment of immortalized and transformed cells with *Ssrp1* floxed alleles we observed an increase in the proportion of lower-molecular-weight DNA and a reduction in the length of the DNA fragments protected by the nucleosomes, indicating nucleosome opening ([Figures 7](#fig7){ref-type="fig"}A, 7B, and [S12](#mmc1){ref-type="supplementary-material"}). 4-OHT caused no changes in primary cells ([Figures 7](#fig7){ref-type="fig"}A, 7B, [S12](#mmc1){ref-type="supplementary-material"}D, and S12E).Figure 7Both FACT Depletion and Tumorigenic Transformation Lead to Chromatin DestabilizationAll data are from *Ssrp1*^*fl/fl*^*;CreERT2*^*+/+*^*\#2* cells.(A and B) Sensitivity of chromatin in cells to digestion with micrococci nuclease (MNase) before and after 4-OHT treatment. (A) Images of capillary electrophoresis generated by Bioanalyzer. Images of one representative replicate from Pr, Im, and Tr cells. Images of other replicates are shown in [Figure S12](#mmc1){ref-type="supplementary-material"}. (B) Distribution of length of DNA fragments corresponding to mono-, di-, and tri-nucleosomes obtained upon MNase digestion of chromatin from 4-OHT-treated and control cells detected by Bioanalyzer. Dots are data obtained in several repetitive experiments with cells isolated from different mice.(C) Metagene profiles of nucleosome distribution obtained by MNase-seq of Pr, Im (\#2), and Tr (\#2) cells before (blue) and after (green) 4-OHT treatment shown separately for gene expression quartiles (RNA-seq). See also [Figures S13](#mmc1){ref-type="supplementary-material"} and [S14](#mmc1){ref-type="supplementary-material"}.(D) Distribution of length of paired-end MNase reads in Pr, Im, and Tr cells with and without 4-OHT treatment.

Next, we digested chromatin from cells with floxed Ssrp1 to the mononucleosomes using two slightly different regimens of MNase treatment to ensure mononucleosome enrichment in all types of cells and sequenced nucleosome protected fragments (MNase-seq). In general, there was high correlation between these two regimens for all cells ([Figures S13](#mmc1){ref-type="supplementary-material"} and [S14](#mmc1){ref-type="supplementary-material"}) and the analysis both samples were combined. [Figure 7](#fig7){ref-type="fig"}C demonstrates metaplots of nucleosome occupancy in all cell variants with floxed *Ssrp1* before and after 4-OHT treatment. We built these plots separately for each transcription quartile from low to high. First, in all cases there was significant difference in nucleosome occupancy between cells with and without FACT; however, quite surprisingly this difference was opposite between primary and transformed cells, with immortalized being in between. The largest difference was seen at genes with high and moderately high transcription (quartiles 3 and 4): whereas in primary cells nucleosome occupancy was slightly increased, in transformed cells it was substantially decreased upon FACT depletion ([Figures 7](#fig7){ref-type="fig"}C and [S14](#mmc1){ref-type="supplementary-material"}). At genes with low and moderate transcription (quartiles 1 and 2) nucleosome occupancy was increased in all types of cells upon FACT removal. Interestingly, nucleosomes were significantly lost before and after coding regions of all genes in transformed cells, but the loss becomes stronger with an increase of gene transcription.

Decrease in nucleosome-protected DNA fragments (135--200 bp length) may be the result of reduced number of nucleosomes (e.g., random loss of nucleosomes or increase in linker DNA length) or presence of nucleosomes in more open state, such as nucleosomes without linker histones or without one H2A/B dimer (subnucleosomal particles) ([@bib49], [@bib43], [@bib50], [@bib29]). To test this we compared distribution of paired-end read length in MNase data. We have found that after 4-OHT treatment there was significant decrease in 147-bp fragment size in transformed cells, slight decrease in immortalized cells, and increase in primary cells ([Figure 7](#fig7){ref-type="fig"}D). Concomitantly, there were more short fragments in transformed and to a lesser extent in immortalized cells and less short fragments in primary cells.

Thus, we observed that depletion of FACT has almost different consequences for normal and transformed cells. Normal cells without FACT have nucleosomes as or even more "stable" than normal cells with FACT: average nucleosome occupancy is increased with higher proportion of longer nucleosome-protected DNA fragments, and nucleosome dynamics are not visibly changed. Stability of nucleosomes in transformed cells without FACT is significantly decreased; there is lower nucleosome occupancy and higher proportion of shorter DNA fragments suggesting the presence of more open nucleosomes or subnucleosomal particles.

Discussion {#sec3}
==========

The goal of our study was to understand why malignant tumor cells are much more dependent on FACT than less malignant and non-tumor cells. FACT function established in cell-free experiments as facilitation of RNA polymerase passage through nucleosomes makes difficult to explain differential cell dependence on FACT, because nucleosomes are present at coding regions of all genes in all mammalian cells. Thus, we designed this study to compare consequences of FACT loss in original FACT-independent cells and cells that we made dependent on FACT via established genetic manipulations, i.e., inactivation of tumor suppressor p53 and overexpression of mutant HRas^V12^ oncogene. These cells as expected became fully transformed, i.e., anchorage independent and forming aggressive tumors in mice, thus representing a model of malignant tumor cells.

Our initial hypothesis was that FACT is needed not for all transcription elongation, but for the most efficient high-rate transcription. In support of this hypothesis, we and others observed correlation between FACT enrichment genome-wide and rates of transcription ([@bib36], [@bib28], [@bib24]). However, inactivation of FACT did not reduce the rates of transcription in any of the tested cells, ruling out the proposition that FACT is needed for transcription elongation.

Although there were some genes with reduced expression following loss of FACT, coding regions of these genes were not enriched with FACT under basal conditions. Moreover, there was a negative correlation between FACT enrichment and changes in gene transcription, suggesting that FACT inhibits transcription of genes.

Thus, FACT enrichment genome-wide depends on transcription, but transcription does not depend on FACT, suggesting that FACT does not facilitate transcription elongation. Indeed, our studies and the existing FACT literature suggest that instead of disassembly, FACT preserves the nucleosomes that are disturbed by the passage of the RNA polymerase ([@bib22]). If RNA polymerase itself or together with other factors destabilizes nucleosomes, the stabilization or reassembly of nucleosomes by FACT will prevent the loss of histones. Furthermore, the model explains why FACT is enriched in proportion to the level of transcription. The more frequently RNA polymerases pass through a gene, the more often nucleosomes are disturbed, increasing the chance of FACT binding.

Our current model of FACT function is consistent with published structural studies that showed that mammalian FACT could only bind nucleosomal components or subnucleosomal particles (e.g., lacking the H2A/H2B dimer) because the FACT-binding epitopes are hidden within the folded nucleosome ([@bib43], [@bib49], [@bib50]). It is also consistent with studies in yeast that showed that FACT is targeted to transcribed chromatin through its recognition of RNA polymerase-disrupted nucleosomes ([@bib32]) and the loss of FACT is accompanied by the loss of histones and pervasive transcription ([@bib13], [@bib14], [@bib34], [@bib35]). Similar observations in plants have also been recently reported ([@bib38]).

If the above model is correct, why is transcription increased following the loss of FACT? There are two potential explanations for this phenomenon, which will require further investigation. First, in the absence of FACT, nucleosomes that are destabilized by the first RNA polymerase passage will be a weaker barrier for subsequent passages by RNA polymerases. Thus, gene transcription will become more efficient. Alternatively, or in addition, nucleosomes may eventually be lost from the transcribed regions, leading to cryptic initiation and pervasive transcription. With short read-based transcription analysis, it is difficult to distinguish between these two scenarios. We expected that cryptic initiation and pervasive transcription would skew the distribution of RNA-seq reads corresponding to the 5′ and -3′ exons of the genes. In line with this we observed higher proportion of reads corresponding to 5′ exons in transformed and immortalized cells upon FACT depletion using RNA-seq.

The most interesting question is why FACT loss is only problematic for transformed and tumor cells if it serves a very basic function of prevention of the loss of histones from destabilized nucleosomes during transcription and replication. Although both processes occur in primary cells, FACT loss is not associated with reduced viability of these cells and destabilization of chromatin. One explanation is that replication and transcription occur at a lower rate in the primary cells than in the immortalized and transformed cells, and therefore the rate of these processes could be one factor that determined the necessity of FACT. However, this hypothesis was disproven by a recent report that demonstrated increased proliferation of mouse embryonic stem cells, which typically have very high replication and transcription rates ([@bib11]), upon FACT KD ([@bib36]).

Another hypothesis of why FACT is essential for transformed and tumor cells is that it is needed for the packaging of DNA for mitosis, which is a constantly ongoing process in these cells. FACT was found to be one of only a few factors that were essential for packaging mitotic chromosomes under cell-free conditions ([@bib47]). However, the ability of primary and other non-tumor cells to pass through mitosis in the absence of FACT shakes this proposition.

The third hypothesis is that FACT prevents nucleosome loss in transformed and tumor cells, in which chromatin is already destabilized compared with non-tumor cells and therefore two chromatin-destabilizing effects, transformation and FACT loss, together drive chromatin state to the critical lethal point. We showed that both transformation and FACT loss reduced nucleosome stability. Nucleosome stability is a well-defined property of nucleosomes in cell-free experiments, which can be measured by different methods, including resistance to increased concentrations of salt and protection of nucleosomal DNA from nuclease digestion. However, in mammalian cells, there are millions of nucleosomes, and their stability differs significantly at different genomic loci and depends on a large number of factors. Therefore, understanding nucleosome stability in the context of cells is more difficult. To make this concept easier, we propose to define nucleosome stability in cells as a degree of this nucleosome interference with transcription. In general, regions of constitutive heterochromatin in mammalian cells have more stable nucleosomes ([@bib42], [@bib6]), whereas nucleosomes in transcribed regions are less stable and more open ([@bib2]). Nucleosomes at AT-rich DNA (e.g., promoters and TSS regions) are also less stable ([@bib31]).

Based on indirect literature data and observations made in the current study, we propose that, in general, chromatin is destabilized upon malignant transformation. It becomes more sensitive to nucleases, has a higher histone exchange rate, and is less restrictive to transcription (judged by the appearance of reads with no features and corresponding to introns). Data available in the literature suggest that changes in the chromatin state may be a universal process that accompanies malignant transformation. Reports have shown that tumors can have reduced expression of linker histone 1 ([@bib46]), their DNA is hypomethylated ([@bib12]). Tumor cells have reduced amount of architectural chromatin proteins (e.g., HP1) that could make chromatin less stable ([@bib8]), and increased levels of HMG box proteins, which can unwrap DNA from nucleosomes at entry and exit points ([@bib25]). In addition, we observed a higher sensitivity of tumor cells to chromatin-destabilizing small molecules, which suggests that chromatin in tumor cells may be less stable under basal conditions than in normal cells ([@bib21], [@bib43]).

We observed an interesting relationship between FACT and transcription in immortalized and transformed cells, which was different from that observed in normal mammalian stem and non-stem cells ([@bib36], [@bib28]). In immortalized cells, FACT enrichment was more proportional to the level of gene transcription than that observed in transformed cells. When FACT was depleted from the immortalized cells, there was a higher increase in transcription of the FACT-enriched genes compared with the transformed cells. Based on these data, the ability of FACT to rebuild nucleosomes at transcribed genes may be stronger in immortalized cells than in transformed cells. In transformed cells, the levels of FACT and FACT enrichment at non-transcribed genes and non-genic regions are higher. Because chromatin is less stable in transformed cells, there is broader pervasive transcription. Thus, FACT function is needed not only at transcribed genes, but genome-wide, which results in smudging of FACT profiles between gene and non-gene regions.

On the background of already destabilized chromatin, the loss of FACT further destabilizes chromatin as judged by the reduction of nucleosome occupancy and shift in the ratio of DNA fragments from longer to shorter. This is partially observed in cells lacking p53, but not in primary cells. In opposite, it looks like loss of FACT makes nucleosomes even more stable, because we observed increased nucleosome occupancy and DNA fragment size in these cells. However, we were not able to detect functional consequences of these changes in primary cells.

Taken together, our findings suggest that FACT is essential for tumor cells to compensate for the general destabilization of chromatin, which cells acquire during the process of transformation. Therefore, the level of FACT in cells may be considered as a measure or marker of chromatin instability in mammalian cells.

Limitations of the Study {#sec3.1}
------------------------

First, we cannot exclude that the absence of FACT in normal cells is compensated by another factor, which prevents nucleosome loss from chromatin during transcription. However, the data showing increase in nucleosome occupancy in normal cells after removal of FACT suggest that most probably either nucleosome organization or FACT function is different between normal and tumor cells. This will require further investigation. Proposed reason of FACT dependency as the presence of less stable chromatin in tumor cells needs to be tested in human tumors, although direct comparison is difficult in this case, because human cells of origin of many cancer types are still unknown. We also do not know what makes chromatin less stable in tumors, and whether this is a cause or consequence of malignant transformation. Currently, we also know very little about the consequences of chromatin destabilization in cells. We recently proposed several mechanisms ([@bib23]), but they have not been explored experimentally. An additional intriguing and unresolved question is why FACT loss makes nucleosomes less stable in transformed cells, whereas more stable in primary cells.
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